Zobrazeno 1 - 10
of 77
pro vyhledávání: '"E‐E Ke"'
Autor:
Hai‐Yan Tu, Kai Yin, Xiaotian Zhao, E‐E Ke, Si‐Pei Wu, Yang‐Si Li, Mei‐Mei Zheng, Si‐Yang Maggie Liu, Chong‐Rui Xu, Yue‐Li Sun, Jia‐Xin Lin, Xiao‐Yan Bai, Yi‐Chen Zhang, Qing Zhou, Jin‐Ji Yang, Wen‐Zhao Zhong, Bing‐Chao Wang, Xu‐Chao Zhang, Dongqin Zhu, Lingling Yang, Qiuxiang Ou, Yi‐Long Wu
Publikováno v:
Molecular Oncology, Vol 17, Iss 8, Pp 1581-1594 (2023)
The efficacy of immunotherapy in advanced HER2‐mutated non‐small‐cell lung cancer (NSCLC) remains incomprehensively studied. A total of 107 NSCLC patients with de novo HER2 mutations were retrospectively studied at Guangdong Lung Cancer Institu
Externí odkaz:
https://doaj.org/article/d5aadd22e14b45079cd59c661d0f474c
Autor:
Yang-Si Li, Wen-Pu Lai, Kai Yin, Mei-Mei Zheng, Hai-Yan Tu, Wei-Bang Guo, Liang Li, Shou-Heng Lin, Zhen Wang, Lu Zeng, Ben-Yuan Jiang, Zhi-Hong Chen, Qing Zhou, Xu-Chao Zhang, Jin-Ji Yang, Wen-Zhao Zhong, Xue-Ning Yang, Bin-Chao Wang, Yi Pan, Hua-Jun Chen, Fa-Man Xiao, Hao Sun, Yue-Li Sun, Xiao-Yan Bai, E.-E. Ke, Jia-Xin Lin, Si-Yang Maggie Liu, Yangqiu Li, Oscar Junhong Luo, Yi-Long Wu
Publikováno v:
Cell Reports, Vol 43, Iss 8, Pp 114613- (2024)
Summary: Leptomeningeal metastases (LMs) remain a devastating complication of non-small cell lung cancer (NSCLC), particularly following osimertinib resistance. We conducted single-cell RNA sequencing on cerebrospinal fluid (CSF) from EGFR-mutant NSC
Externí odkaz:
https://doaj.org/article/0665f6377f1241e58a85cf57da13bbbc
Autor:
E-E Ke, Yi-Long Wu
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 10 (2016)
First-line afatinib significantly improved progression-free survival, patient-reported outcomes, and quality of life compared with chemotherapy regimens in patients with advanced epidermal-growth-factor-receptor ( EGFR ) mutation-positive non-small c
Externí odkaz:
https://doaj.org/article/1598e1b85f214213a7bac5c49cfdd28d
Autor:
Jia−Tao Zhang, Song Dong, Li−Yan Ji, Jia−Ying Zhou, Zhi− Hong Chen, Jian Su, Qing−Ge Zhu, Meng−Min Wang, E−E. Ke, Hao Sun, Xue−Tao Li, Jin−Ji Yang, Qing Zhou, Xu− Chao Zhang, Xuan Gao, Xue−Ning Yang, Xuefeng Xia, Xin Yi, Wen−Zhao Zhong, Yi−Long Wu
Publikováno v:
Thoracic Cancer, Vol 13, Iss 9, Pp 1333-1341 (2022)
Abstract Background Starting with low metastatic capability, T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers (NSCLCs) constitute a unique tumor subset, as with a large tumor size but no regional or distant metastases. We systematically inves
Externí odkaz:
https://doaj.org/article/fbd0266b6f0b4073a1deb47c9ac00d60
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jia-Xin Lin, Yi-Long Wu, Jie Huang, Xiao-Yan Bai, Ri-Qiang Liao, Dongqin Zhu, Xu-Chao Zhang, Yang-Si Li, Yue-Li Sun, Ben-Yuan Jiang, E-E Ke, Xue Wu, Hua-Jun Chen, Ruoying Yu, Bin-Chao Wang, Bing-Fei Xu, Xiaoling Tong, Qing Zhou, Jin-Ji Yang, Hai-Yan Tu, Ming-Ying Zheng
Publikováno v:
Clinical lung cancer. 23(2)
Background Pleural effusion (PE) has been one of the promising sources of liquid biopsy in advanced lung cancer patients. However, its clinical utility is not widely accepted due to the lack of full estimation of its potential versus routine clinical
Autor:
Hai-Yan Tu, Kai Yin, E-E Ke, Si-Pei Wu, Xiaotian Zhao, Yang-Si Li, Mei-Mei Zheng, Si-Yang Maggie Liu, Yue-Li Sun, Jia-Xin Lin, Xiao-Yan Bai, Yi-Chen Zhang, Qing Zhou, Jin-Ji Yang, Wenzhao Zhong, Bin-Chao Wang, Dongqin Zhu, Lingling Yang, Qiuxiang Ou, Yi-Long Wu
Publikováno v:
Journal of Clinical Oncology. 40:2591-2591
2591 Background: Immune checkpoint inhibitors (ICIs) have suboptimal efficacy in non-small cell lung cancer (NSCLC) patients with ERBB2 mutations, including ERBB2 exon 20 insertions. This study aims to investigate the efficacy of ICIs and immune char
Autor:
Xin Yi, Yi-Long Wu, Song Dong, Xue-Ning Yang, Zhi-Hong Chen, Meng-Min Wang, Xu-Chao Zhang, Jian Su, Pansong Li, Xue-Tao Li, Hao Sun, Li-Yan Ji, Qing Zhou, Jia-Tao Zhang, Xue-Feng Xia, Jia-Ying Zhou, E-E Ke, Jin-Ji Yang, Qing-Ge Zhu, Wen-Zhao Zhong
Publikováno v:
SSRN Electronic Journal.